Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2013 1
2015 1
2016 1
2017 2
2018 3
2019 2
2020 2
2021 4
2022 3
2023 5
2024 11
2025 10
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma.
Blank CU, Lucas MW, Scolyer RA, van de Wiel BA, Menzies AM, Lopez-Yurda M, Hoeijmakers LL, Saw RPM, Lijnsvelt JM, Maher NG, Pulleman SM, Gonzalez M, Torres Acosta A, van Houdt WJ, Lo SN, Kuijpers AMJ, Spillane A, Klop WMC, Pennington TE, Zuur CL, Shannon KF, Seinstra BA, Rawson RV, Haanen JBAG, Ch'ng S, Naipal KAT, Stretch J, van Thienen JV, Rtshiladze MA, Wilgenhof S, Kapoor R, Meerveld-Eggink A, Grijpink-Ongering LG, van Akkooi ACJ, Reijers ILM, Gyorki DE, Grünhagen DJ, Speetjens FM, Vliek SB, Placzke J, Spain L, Stassen RC, Amini-Adle M, Lebbé C, Faries MB, Robert C, Ascierto PA, van Rijn R, van den Berkmortel FWPJ, Piersma D, van der Westhuizen A, Vreugdenhil G, Aarts MJB, Stevense-den Boer MAM, Atkinson V, Khattak M, Andrews MC, van den Eertwegh AJM, Boers-Sonderen MJ, Hospers GAP, Carlino MS, de Groot JB, Kapiteijn E, Suijkerbuijk KPM, Rutkowski P, Sandhu S, van der Veldt AAM, Long GV. Blank CU, et al. Among authors: amini adle m. N Engl J Med. 2024 Nov 7;391(18):1696-1708. doi: 10.1056/NEJMoa2402604. Epub 2024 Jun 2. N Engl J Med. 2024. PMID: 38828984 Clinical Trial.
Zanubrutinib-associated ecchymotic lesions.
Belkaïd S, Amini-Adle M. Belkaïd S, et al. Among authors: amini adle m. Lancet Haematol. 2024 Sep;11(9):e708. doi: 10.1016/S2352-3026(24)00213-8. Lancet Haematol. 2024. PMID: 39181616 No abstract available.
Combination of encorafenib and binimetinib followed by ipilimumab and nivolumab versus ipilimumab and nivolumab in patients with advanced melanoma with BRAFV600E or BRAFV600K mutations (EBIN): an international, open-label, randomised, controlled, phase 2 study.
Robert C, Kicinski M, Dutriaux C, Routier É, Govaerts AS, Bührer E, Neidhardt EM, Durando X, Baroudjian B, Saiag P, Gaudy-Marqueste C, Ascierto PA, Arance A, Russillo M, Perrot JL, Mortier L, Aubin F, Dalle S, Grange F, Muñoz-Couselo E, Mary-Prey S, Amini-Adle M, Mansard S, Lebbe C, Funck-Brentano E, Monestier S, Eggermont AMM, Oppong F, Wijnen L, Schilling B, MandalÁ M, Lorigan P, van Akkooi ACJ. Robert C, et al. Among authors: amini adle m. Lancet Oncol. 2025 Jun;26(6):781-794. doi: 10.1016/S1470-2045(25)00133-0. Lancet Oncol. 2025. PMID: 40449497 Clinical Trial.
Bone tumour with CRTC1::TRIM11 gene rearrangement.
Baltres A, Meurgey A, Bourbotte-Salmon F, Gouin F, Amini-Adle M, Tirode F, Pissaloux D, de la Fouchardière A. Baltres A, et al. Among authors: amini adle m. Pathology. 2025 Aug;57(5):665-667. doi: 10.1016/j.pathol.2025.01.009. Epub 2025 Apr 3. Pathology. 2025. PMID: 40312221 No abstract available.
Gastric signet-ring cell adenocarcinoma masquerading as sarcoidosis.
Belkaïd S, Crumbach L, de Bernardi A, Darnis S, Bouquerel M, Neuhart A, Assaad S, Amini-Adle M. Belkaïd S, et al. Among authors: amini adle m. Lancet Oncol. 2024 Apr;25(4):e173. doi: 10.1016/S1470-2045(24)00105-0. Lancet Oncol. 2024. PMID: 38547901 No abstract available.
Measurement of the severity related to cutaneous neurofibromas in neurofibromatosis type 1: Development and validation of the Nef-ASI.
Fertitta L, Jannic A, Bergqvist C, Delique V, Armand ML, Moryousef S, Ferkal S, Zehou O, Ayache H, Le Corvoisier P, Audureau E, Hebrard B, Lunati-Rozie A, Funalot B, Sarin KY, Blakeley JO, Romo CG, Berman Y, Le LQ, Ezzedine K, Wolkenstein P; FIMARAD group. Fertitta L, et al. J Am Acad Dermatol. 2026 Feb;94(2):641-644. doi: 10.1016/j.jaad.2025.10.025. Epub 2025 Oct 6. J Am Acad Dermatol. 2026. PMID: 41061983 Free article. No abstract available.
Cemiplimab removed from reimbursable drugs in France.
Pham F, Reynaud B, Favier B, Darnis S, Amini-Adle M. Pham F, et al. Among authors: amini adle m. Eur J Cancer. 2021 May;149:11-13. doi: 10.1016/j.ejca.2021.02.041. Epub 2021 Apr 1. Eur J Cancer. 2021. PMID: 33812142 No abstract available.
Vesiculobullous skin lesions on the hands and face.
Belkaïd S, Amini-Adle M. Belkaïd S, et al. Among authors: amini adle m. JAAD Case Rep. 2024 May 15;49:88-90. doi: 10.1016/j.jdcr.2024.05.010. eCollection 2024 Jul. JAAD Case Rep. 2024. PMID: 38938701 Free PMC article. No abstract available.
43 results